Evidence map›Paper›PMID 35571512›Full record

ArticleNeural computing & applications2022

Statistical analysis of blood characteristics of COVID-19 patients and their survival or death prediction using machine learning algorithms.

Rahil Mazloumi, Seyed Reza Abazari, Farnaz Nafarieh, Amir Aghsami, Fariborz Jolai

Abstract read
In one paragraph

Article in Neural computing & applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rahil MazloumiSchool of Industrial and Systems Engineering, College of Engineering, University of Tehran, P.O. Box, Tehran, 11155-4563 Iran.
Seyed Reza AbazariSchool of Industrial and Systems Engineering, College of Engineering, University of Tehran, P.O. Box, Tehran, 11155-4563 Iran.
Farnaz NafariehSchool of Industrial and Systems Engineering, College of Engineering, University of Tehran, P.O. Box, Tehran, 11155-4563 Iran.
Amir AghsamiSchool of Industrial and Systems Engineering, College of Engineering, University of Tehran, P.O. Box, Tehran, 11155-4563 Iran.ORCID 0000-0003-0175-2979
Fariborz JolaiSchool of Industrial and Systems Engineering, College of Engineering, University of Tehran, P.O. Box, Tehran, 11155-4563 Iran.ORCID 0000-0003-0824-8513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study's main purpose is to provide helpful information using blood samples from COVID-19 patients as a non-medical approach for helping healthcare systems during the pandemic. Also, this paper aims to evaluate machine learning algorithms for predicting the survival or death of COVID-19 patients. We use a blood sample dataset of 306 infected patients in Wuhan, China, compiled by Tangji Hospital. The dataset consists of blood's clinical indicators and information about whether patients are recovering or not. The used methods include K-nearest neighbor (KNN), decision tree (DT), logistic regression (LR), support vector machine (SVM), random forest (RF), stochastic gradient descent (SGD), bagging classifier (BC), and adaptive boosting (AdaBoost). We compare the performance of machine learning algorithms using statistical hypothesis testing. The results show that the most critical feature is age, and there is a high correlation between LD and CRP, and leukocytes and CRP. Furthermore, RF, SVM, DT, AdaBoost, DT, and KNN outperform other machine learning algorithms in predicting the survival or death of COVID-19 patients.

Indexed as

Blood sampleCOVID-19Healthcare systemMachine learningStatistical analysis

Identifiers

PMID35571512
PMCPMC9092327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.